Full Text (PDF)
Abstract
Objectives: As it is known, the low doses of Heparin’s analogues have the antiproliferative and immunomodulator activities. This research aims to evaluate the activity of enoxaparin by using the low doses.
Materials and methods: 21 patients with lichen planus diagnosis have been cured within 12 weeks. 3 mg of enoxaparin has been used for subcutaneus injection to all of patients weekly. The efficient and reliable data has been saved.
Results: The perfect recovery has been observed 15 (71%) of 21 patients, the distinct recovery has been observed 4 (19%) of 21 patients. The treatment has not given response on 2 (9%) of 21 patients. The best score has been received on acute generalized type of Lichen Planus.
Conclusions: As the result; it has been reported that enoxaparin treatment can be an effective choice in Lichen Planus medication.
Keywords
License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article Type: Research Article
J Clin Exp Invest, Volume 3, Issue 2, June 2012, 172-173
https://doi.org/10.5799/ahinjs.01.2012.02.0138
Publication date: 12 Jun 2012
Article Views: 2741
Article Downloads: 1716
Open Access References How to cite this article